D.E. Griswold

1.9k total citations
23 papers, 1.7k citations indexed

About

D.E. Griswold is a scholar working on Immunology, Pathology and Forensic Medicine and Pharmacology. According to data from OpenAlex, D.E. Griswold has authored 23 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Immunology, 7 papers in Pathology and Forensic Medicine and 6 papers in Pharmacology. Recurrent topics in D.E. Griswold's work include Neutrophil, Myeloperoxidase and Oxidative Mechanisms (8 papers), Cardiac Ischemia and Reperfusion (7 papers) and Cardiac Fibrosis and Remodeling (6 papers). D.E. Griswold is often cited by papers focused on Neutrophil, Myeloperoxidase and Oxidative Mechanisms (8 papers), Cardiac Ischemia and Reperfusion (7 papers) and Cardiac Fibrosis and Remodeling (6 papers). D.E. Griswold collaborates with scholars based in United States and Australia. D.E. Griswold's co-authors include Leonard M. Hillegass, B Brickson, C R Albrightson-Winslow, G Feuerstein, Henry M. Sarau, William J. Price, Frank C. Barone, Robert Clark, Ray F. White and Edward F. Smith and has published in prestigious journals such as The Journal of Immunology, Circulation Research and Stroke.

In The Last Decade

D.E. Griswold

23 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
D.E. Griswold United States 15 493 403 394 231 221 23 1.7k
Leonard M. Hillegass United States 20 681 1.4× 497 1.2× 396 1.0× 279 1.2× 232 1.0× 42 2.1k
Olivier Chappey France 18 617 1.3× 283 0.7× 212 0.5× 494 2.1× 211 1.0× 32 2.4k
J.L. Witztum United States 5 427 0.9× 778 1.9× 206 0.5× 161 0.7× 294 1.3× 5 2.0k
David Hosford France 18 330 0.7× 190 0.5× 183 0.5× 215 0.9× 110 0.5× 36 1.2k
S D Yan United States 11 843 1.7× 474 1.2× 452 1.1× 891 3.9× 347 1.6× 18 3.5k
Sho‐ichi Yamagishi Japan 33 899 1.8× 349 0.9× 412 1.0× 580 2.5× 336 1.5× 61 3.6k
So Youn Park South Korea 25 624 1.3× 311 0.8× 228 0.6× 348 1.5× 67 0.3× 56 1.6k
Ling Rong China 23 822 1.7× 404 1.0× 249 0.6× 341 1.5× 302 1.4× 36 3.2k
Kazunao Kondo Japan 21 440 0.9× 162 0.4× 144 0.4× 129 0.6× 74 0.3× 69 1.4k
E. Schleicher Germany 26 791 1.6× 149 0.4× 88 0.2× 416 1.8× 155 0.7× 77 2.5k

Countries citing papers authored by D.E. Griswold

Since Specialization
Citations

This map shows the geographic impact of D.E. Griswold's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D.E. Griswold with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D.E. Griswold more than expected).

Fields of papers citing papers by D.E. Griswold

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D.E. Griswold. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D.E. Griswold. The network helps show where D.E. Griswold may publish in the future.

Co-authorship network of co-authors of D.E. Griswold

This figure shows the co-authorship network connecting the top 25 collaborators of D.E. Griswold. A scholar is included among the top collaborators of D.E. Griswold based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D.E. Griswold. D.E. Griswold is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Das, Archik, D.E. Griswold, Theodore J. Torphy, & Lily Li. (2006). Biopharmaceutical Therapeutics for Asthma Remodeling. Current Pharmaceutical Design. 12(25). 3233–3240. 4 indexed citations
2.
Boehm, Jeffrey C., Margaret E. Sorenson, Ravi S. Garigipati, et al.. (1996). 1-Substituted 4-Aryl-5-pyridinylimidazoles:  A New Class of Cytokine Suppressive Drugs with Low 5-Lipoxygenase and Cyclooxygenase Inhibitory Potency. Journal of Medicinal Chemistry. 39(20). 3929–3937. 97 indexed citations
3.
Barone, Frank C., Leonard M. Hillegass, Maritsa N. Tzimas, et al.. (1995). Time-related changes in myeloperoxidase activity and leukotriene B4 receptor binding reflect leukocyte influx in cerebral focal stroke. Molecular and Chemical Neuropathology. 24(1). 13–30. 95 indexed citations
4.
Chabot‐Fletcher, Marie, David C. Underwood, John Breton, et al.. (1995). Pharmacological characterization of SB 202235, a potent and selective 5-lipoxygenase inhibitor: effects in models of allergic asthma.. Journal of Pharmacology and Experimental Therapeutics. 273(3). 1147–1155. 12 indexed citations
5.
Winkler, Julia, Alfred N. Fonteh, Andrew B. Nixon, et al.. (1995). Effects of CoA-independent transacylase inhibitors on the production of lipid inflammatory mediators.. Journal of Pharmacology and Experimental Therapeutics. 274(3). 1338–1347. 39 indexed citations
6.
Smith, Edward F., D.E. Griswold, John Egan, et al.. (1993). Reduction of myocardial reperfusion injury with human soluble complement receptor type 1 (BRL 55730). European Journal of Pharmacology. 236(3). 477–481. 38 indexed citations
7.
Breton, John, Paul M. Keller, Marie Chabot‐Fletcher, et al.. (1993). Use of a continous assay of oxygen consumption to evaluate the pharmacology of 5-lipoxygenase inhibitors. Prostaglandins Leukotrienes and Essential Fatty Acids. 49(6). 929–937. 9 indexed citations
8.
9.
Rabinovici, Reuven, Leonard M. Hillegass, D.E. Griswold, et al.. (1992). Role of complement in endotoxin/platelet-activating factor-induced lung injury. The Journal of Immunology. 149(5). 1744–1750. 54 indexed citations
10.
Barone, Frank C., Leonard M. Hillegass, William J. Price, et al.. (1991). Polymorphonuclear leukocyte infiltration into cerebral focal ischemic tissue: Myeloperoxidase activity assay and histologic verification. Journal of Neuroscience Research. 29(3). 336–345. 350 indexed citations
11.
Griswold, D.E., et al.. (1991). Analgetic Activity of SK&F 105809, a Dual Inhibitor of Arachidonic Acid Metabolism. Birkhäuser Basel eBooks. 32. 113–117. 14 indexed citations
12.
Nichols, Andrew J., Teresa S. Sellers, D.E. Griswold, et al.. (1991). Reduction in Myocardial Ischemic/Reperfusion Injury and Neutrophil Accumulation After Therapeutic Administration of Streptokinase. Journal of Cardiovascular Pharmacology. 18(5). 729–738. 8 indexed citations
13.
Rabinovici, Reuven, Klaus Esser, Paul G. Lysko, et al.. (1991). Priming by platelet-activating factor of endotoxin-induced lung injury and cardiovascular shock.. Circulation Research. 69(1). 12–25. 51 indexed citations
14.
Hillegass, Leonard M., D.E. Griswold, B Brickson, & C R Albrightson-Winslow. (1990). Assessment of myeloperoxidase activity in whole rat kidney. Journal of Pharmacological Methods. 24(4). 285–295. 470 indexed citations
15.
Egan, J., D.E. Griswold, Leonard M. Hillegass, et al.. (1989). Selective antagonism of peptidoleukotriene response does not reduce myocardial damage opr neutrophil accumulation following coronary artery occlusion with reperfusion. Prostaglandins. 37(5). 597–613. 9 indexed citations
16.
Griswold, D.E., et al.. (1989). Evaluation of the effect of Evan's blue and triphenyltetrazolium chloride dyes on myeloperoxidase activity in canine cardiac tissue. Journal of Pharmacological Methods. 21(1). 13–19. 24 indexed citations
17.
18.
Smith, Edward F., D.E. Griswold, J. Egan, Leonard M. Hillegass, & Michael J. DiMartino. (1989). Reduction of Myocardial Damage and Polymorphonuclear Leukocyte Accumulation Following Coronary Artery Occlusion and Reperfusion by the Thromboxane Receptor Antagonist BM 13.505. Journal of Cardiovascular Pharmacology. 13(5). 715–722. 27 indexed citations
19.
Griswold, D.E., Leonard M. Hillegass, David E. Hill, J. Egan, & Edward F. Smith. (1988). Method for quantification of myocardial infarction and inflammatory cell infiltration in rat cardiac tissue. Journal of Pharmacological Methods. 20(3). 225–235. 34 indexed citations
20.
Smith, Edward F., J. Egan, Peter J. Bugelski, et al.. (1988). Temporal relation between neutrophil accumulation and myocardial reperfusion injury. American Journal of Physiology-Heart and Circulatory Physiology. 255(5). H1060–H1068. 75 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Leonard M. Hillegass Breakdown of academic impact, for papers by Olivier Chappey Breakdown of academic impact, for papers by J.L. Witztum Breakdown of academic impact, for papers by David Hosford Breakdown of academic impact, for papers by S D Yan Breakdown of academic impact, for papers by Sho‐ichi Yamagishi Breakdown of academic impact, for papers by So Youn Park Breakdown of academic impact, for papers by Ling Rong Breakdown of academic impact, for papers by Kazunao Kondo Breakdown of academic impact, for papers by E. Schleicher
Rankless by CCL
2026